Prenatal Genetic Testing

Empowering Expecting Mothers with Early, Safe, and Personalized Prenatal Insights

Our NIPT screens for chromosomal issues as early as 10 weeks. Safe, accurate, and tailored for all pregnancies, it delivers fast results to support a healthy, informed pregnancy journey.

  • NIPT analyzes fetal DNA with >99% sensitivity for Down syndrome and chromosomal abnormalities as early as 10 weeks, offering a risk-free alternative to invasive tests.
  • NIPT is available for singleton, twin, IVF, and donor pregnancies, detecting trisomies, sex chromosome aneuploidies, and microdeletions.
  • Performed in certified labs, results are available in 7–10 days with clear guidance for next steps, including genetic counseling and confirmatory testing if needed.
Product Hero Image
Science Behind It image
Science Behind It

Backed by Science, Built for You

Non-Invasive Prenatal Testing (NIPT) is a cutting-edge screening method that analyzes cell-free fetal DNA (cffDNA) in a pregnant woman's blood to assess the risk of common chromosomal conditions. Unlike traditional invasive diagnostic tests such as amniocentesis or chorionic villus sampling (CVS), NIPT is safe, highly accurate, and can be performed as early as 10 weeks of pregnancy.

Why is NIPT Important?

  • Chromosomal abnormalities occur in 1 in 150 live births, with Down syndrome (Trisomy 21) being the most common.
  • NIPT has a detection rate of over 99% for Trisomy 21 and high sensitivity for other conditions like Trisomy 18 (Edwards syndrome) and Trisomy 13 (Patau syndrome).
  • Compared to traditional first-trimester screening (which includes ultrasound and serum markers), NIPT offers higher accuracy and reduces unnecessary invasive procedures.
Indication of Use

Who Should Consider NIPT?

NIPT is available for singleton and twin pregnancies. Some tests also support pregnancies conceived via egg donation or surrogacy.

All pregnant women, regardless of age or risk factors, as an early and reliable screening tool.

Women aged 35 or older, who have a higher risk of chromosomal abnormalities.

Pregnancies with abnormal results from ultrasound or first-trimester screening tests.

Pregnancies conceived through assisted reproductive technology (IVF, ICSI, donor egg/sperm).

Test Performance

Why Choose us

We can help you:

Test Performance image 1

Child Syndrome

  • Trisomy 21 (Down Syndrome): Sensitivity (>99%), Specificity (>99%), Positive Predictive Value (PPV) is High
  • Trisomy 18 (Edwards syndrome): Sensitivity (97-99%). Positive Predictive Value (PPV) is Moderate
  • Trisomy 13 (Patau syndrome): Sensitivity (80-99%). Specificity (>99%). Positive Predictive Value (PPV) is Moderate
Test Performance image 2

Sex Chromosome Aneuploidies (Monosomy X, XXY, XYY, XXX)

Sensitivity (90-95%), Specificity (>99%), Positive Predictive Value (PPV) is Varies

Test Performance image 3

Microdeletions

Sensitivity 70-90%, Specificity (>99%), Positive Predictive Value (PPV) is Varies

Product Logistics of the test Image
Logistics of the Test

Fast, Secure, & Science-Backed Testing

Where It's Done:

  • Sample collection is done at partner hospitals, clinics, or desginated collection centers.
  • Home sample collection options may be available in certain regions.

Test Process:

  • A small blood sample (typically 10ml) is drawn from the mother's arm
  • The sample is sent to a specialized CAP/CLIA-certified laboratory for processing.
  • Result are analyzed using high-throughput sequencing and bioinformatics analysis.

Turnaround Time (TAT):

  • 7-10 days or standard tests.
  • Expedited options may be available upon request.
Your Journey

What Happens After You Get Your Results?

Your Journey image 1
Guidelines from Experts

Backed by Science, Trusted by Experts

Guideline image 1

American College of Obstetricians and Gynecologists (ACOG)

Recommends NIPT for all pregnant women, regardless of age.

Guideline image 2

International Society for Prenatal Diagnosis (ISPD)

Supports offering NIPT as a first-tier screening test.

Guideline image 3

National Health Service (NHS UK)

Includes NIPT in their screening program for high-risk pregnancies.

Guideline image 4

Indonesian Society of Obstetrics and Gynecology (POGI)

POGI (Indonesian Obstetrics and Gynecology Association) supports and encourages the use of NIPT (Non-Invasive Prenatal Testing) as a genetic screening method to detect chromosomal abnormalities in the fetus, such as Down Syndro...

What Report Do I Get?

NIPT Sample Report

A safer, less invasive test compared to traditional amniocentesis, using only the mother’s blood sample to accurately check for fetal genetic conditions.

  • Low risk for both mother and fetus.
  • Detects various genetic conditions, including rare ones.
  • Trusted results backed by research from 147,000 pregnancies.
what-you-get-image
Get Your Test Now

Better Health, Backed by Genetics - At the Right Price

Choose the right package for you:

NIPT Testing image
NIPT Testing

Book a consultation with our doctor and start your journey with our test.

Find the right DNA test for you and your loved ones

Unlock total genetic insights to guide your health, nutrition, and wellness journey with personalized and preventive precision

For Individuals

Find our DNA Test product to align with your Goals